Want to see IN:KOVAI full AI Analyst Report?
Kovai Medical Center & Hospital Ltd. (KOVAI) AI Stock Analysis
Top Page
Kovai Medical Center & Hospital Ltd.
(NSE:KOVAI)
The score is primarily driven by solid financial performance (steady growth, healthy profitability, and strong operating cash flow) and supportive technical trend signals (price above key moving averages with positive momentum). This is offset by less attractive valuation (P/E ~26.9 and very low dividend yield) and financial variability risks from margin pressure and uneven free cash flow.
Kovai Medical Center & Hospital Ltd. (KOVAI) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 79.52B
- Dividend Yield
- 0.26%
- Average Volume (3M)
- 759
- Price to Earnings (P/E)
- 25.2
- Beta (1Y)
- 0.50
- Revenue Growth
- 14.96%
- EPS Growth
- 14.62%
- Country
- India
- Employees
- 6,885
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Care Facilities
Kovai Medical Center & Hospital Ltd. Business Overview & Revenue Model
Company Description
Kovai Medical Center and Hospital Limited, founded in 1985 and based in Coimbatore, India, provides a comprehensive suite of hospital and educational services. The company operates through two primary divisions: Healthcare Services and Education Serv...
How the Company Makes Money
KOVAI primarily makes money by delivering hospital-based healthcare services and charging patients (or their insurers/employers/government schemes, where applicable) for medical treatment and related services. Key revenue streams typically include: (...
Kovai Medical Center & Hospital Ltd. Financial Statement Overview
Summary
Strong and improving operating cash flow and steady revenue growth support the score, alongside solid profitability and a strengthening equity base. The score is tempered by margin volatility (profits not scaling consistently with revenue) and choppy free cash flow, including a negative year, which adds uncertainty to near-term return capacity.
Income Statement
78PositiveBalance Sheet
74PositiveCash Flow
70Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.42B | 15.86B | 13.71B | 12.20B | 10.19B | 9.04B |
| Gross Profit | 7.47B | 5.01B | 4.63B | 6.23B | 7.36B | 6.48B |
| EBITDA | 4.87B | 4.67B | 4.08B | 3.62B | 2.88B | 2.72B |
| Net Income | 2.53B | 2.44B | 2.09B | 1.80B | 1.16B | 1.04B |
Balance Sheet | ||||||
| Total Assets | 0 | 20.66B | 18.00B | 14.38B | 14.42B | 13.43B |
| Cash, Cash Equivalents and Short-Term Investments | 3.45B | 3.47B | 2.71B | 2.08B | 2.47B | 1.96B |
| Total Debt | 0 | 4.03B | 4.15B | 3.10B | 5.11B | 5.50B |
| Total Liabilities | -13.19B | 7.47B | 7.14B | 5.50B | 7.23B | 7.33B |
| Stockholders Equity | 13.19B | 13.19B | 10.86B | 8.89B | 7.19B | 6.09B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 1.02B | -294.49M | 2.06B | 1.36B | 1.63B |
| Operating Cash Flow | 0 | 3.54B | 3.24B | 3.44B | 2.63B | 2.62B |
| Investing Cash Flow | 0 | -2.51B | -3.52B | -1.38B | -1.27B | -990.95M |
| Financing Cash Flow | 0 | -295.91M | 913.67M | -2.43B | -857.03M | -1.19B |
Kovai Medical Center & Hospital Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KOVAI, the sentiment is Negative. The current price of 5808.45 is below the 20-day moving average (MA) of 5891.89, below the 50-day MA of 6008.00, and above the 200-day MA of 5661.48, indicating a neutral trend. The MACD of -48.73 indicates Negative momentum. The RSI at 40.78 is Neutral, neither overbought nor oversold. The STOCH value of 59.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:KOVAI.
Kovai Medical Center & Hospital Ltd. Peers Comparison
Overall Rating
IN:ARTEMISMED80Outperform
IN:YATHARTH75Outperform
IN:INDRAMEDCO71.4Outperform
IN:KOVAI70Outperform
IN:JLHL59Neutral
IN:SHALBY43Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 80Outperform | INR 46.26B | 38.38 | ― | 0.15% | 14.96% | 20.76% | |
| 75Outperform | INR 89.42B | 49.30 | ― | 0.05% | 44.00% | 24.10% | |
| 71Outperform | INR 27.97B | 14.90 | ― | 1.31% | 10.92% | 12.12% | |
| 70Outperform | INR 63.56B | 25.16 | ― | 0.26% | 14.96% | 14.62% | |
| 59Neutral | INR 84.02B | 45.27 | ― | 0.08% | 16.71% | -6.09% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 43Neutral | INR 13.06B | 34.08 | ― | ― | 6.50% | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:KOVAI | Kovai Medical Center & Hospital Ltd. | 5808.45 | -511.56 | -8.09% | |
| IN:ARTEMISMED | Artemis Medicare Services Ltd. | 292.20 | 47.66 | 19.49% | |
| IN:INDRAMEDCO | Indraprastha Medical Corporation Limited | 305.15 | -263.62 | -46.35% | |
| IN:JLHL | Jupiter Life Line Hospitals Ltd. | 256.30 | -57.49 | -18.32% | |
| IN:SHALBY | Shalby Ltd. | 120.90 | -123.30 | -50.49% | |
| IN:YATHARTH | Yatharth Hospital and Trauma Care Services Limited | 928.05 | 114.33 | 14.05% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 15, 2026